Arkolith/Insider Trading/CLSD/Form 4

Lasezkay George M

CEO, DirectorClearside Biomedical, Inc. (CLSD) · full profile →Form 4 · filed Jan 19, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$23K
Net Open-Market Flow
-$23K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 19, 2024Sell(S)18K$1.27$23K467K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 18, 2024Grant(A)440K—$0440K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-24-001960) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML